A 12-week prospective open-label study on 20 autistic children and adolescents showed YKS might be effective in treating hyperactivity, noncompliance, irritability, and agitation, though large-scale placebo-controlled trials are required
The GH/IGF-1 axis in ageing and longevity
Quick Reference: Standard Protocol Community-documented protocol: 250 mcg subcutaneous in the morning, 3 days per week, for 8-week cycles -- far below the 2.4 mg weekly clinical trial dose, reflecting conservative research-peptide practice
Tranexamic Acid and Glutathione eye cream targeting dark circles and pigmentation
Improves Strength and Accelerates Muscle Growth One of the reasons that athletes, in particular, love peptide therapy is because of its ability to increase the production of testosterone
It seems that the antagonistic pleiotropy of insulin/IGF-1 signaling has profound effects on both the healthspan and lifespan of mammalian species